Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Breast (Edinburgh, Scotland)|May 3, 2008
Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studiesAlessandra Fabi, Giulio Metro, Gianluigi Ferretti, et al.
Scientific Reports|September 3, 2024
Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancerSerena Di Cosimo, Marco Silvestri, Cinzia De Marco, et al.
Cancer Medicine|March 20, 2023
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinomaMarco Silvestri, Trung Nghia Vu, Federico Nichetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targetingPablo Matar, Federico Rojo, Raúl Cassia, et al.
Anticancer Research|July 28, 2004
Epirubicin plus docetaxel in metastatic breast cancer: escalating dose does not improve efficacy. A phase II studyAlessandra Fabi, Paola Papaldo, Maria Simona Pino, et al.
Tumori|August 27, 2019
High consistency between characteristics of primary intraductal breast cancer and subtype of subsequent ipsilateral invasive cancerMassimiliano Gennaro, Elisabetta Meneghini, Paolo Baili, et al.
Breast (Edinburgh, Scotland)|May 18, 2018
Dynamics of the hazard for distant metastases after ipsilateral breast tumor recurrence according to estrogen receptor status: An analysis of 2851 patientsMassimiliano Gennaro, Serena Di Cosimo, Ilaria Ardoino, et al.
Breast (Edinburgh, Scotland)|August 13, 2023
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in ItalyAlberto Zambelli, Marina Cazzaniga, Nicla La Verde, et al.
Springerplus|February 18, 2016
Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational studyNicla La Verde, Elena Biagioli, Chiara Gerardi, et al.
Tumori|May 14, 2016
Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancerArpine Gevorgyan, Giacomo Bregni, Giulia Galli, et al.
Pageof 16